GFAP and ischemic stroke: Together, these results indicated that administration of 70 mg/kg ambroxol could increase the percentage of DCX+ cells, while decrease the portion of GFAP+ cells in penumbra, to some degree, induced by ischemic stroke, and finally reduced infarct volume to potentiate functional recovery.